Interés Humano

Pfizer afirma que su vacuna contra la covid-19 para niños supera el 90% de eficacia

Panel de la FDA decidirá el martes si avala la inoculación para los menores entre 5 y 11 años

A teenage boy (R) receives the Pfizer vaccine against Covid-19 at a sports complex in Marikina, suburban Manila on October 22, 2021, after the national government expanded its innoculation program against Covid-19 to children with comorbidities aged 12-17. (Photo by Ted ALJIBE / AFP)
A teenage boy (R) receives the Pfizer vaccine against Covid-19 at a sports complex in Marikina, suburban Manila on October 22, 2021, after the national government expanded its innoculation program against Covid-19 to children with comorbidities aged 12-17. (Photo by Ted ALJIBE / AFP) TED ALJIBE
‌
‌

‌

‌
‌

‌

‌